Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
15 employees
Jupiter Neurosciences: A biotech firm specializing in treatments for Alzheimer's and rare diseases.
HQ
Founded
2015
Jupiter Neurosciences, founded with the mission to significantly impact patients and society, is a biotechnology company specializing in treatments for Alzheimer's disease and rare neurological disorders. The company focuses on developing JOTROL™, a clinical-stage drug platform aimed at treating neuroinflammation. Utilizing their proprietary Micellar Technology, Jupiter Neurosciences has created the first resveratrol product that safely reaches therapeutic levels without gastrointestinal side effects, opening up treatment possibilities for various conditions.
Notable figures affiliated with Jupiter Neurosciences include experts in neurology and biotechnology, although specific names are not provided. The company has attracted attention from investors interested in innovative treatments for neurodegenerative diseases. Key achievements include advancing JOTROL™ to clinical stages and demonstrating its potential to safely treat neuroinflammation. Jupiter Neurosciences' impact lies in its pioneering approach to addressing unmet medical needs in both common and rare neurological disorders.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Pharmaceuticals
Technology
Biotech
Tags
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Jupiter Neurosciences founded?
Jupiter Neurosciences was founded in 2015.
Where is Jupiter Neurosciences's headquarters located?
Jupiter Neurosciences's headquarters is located in Jupiter, FL, US.
How many employees does Jupiter Neurosciences have?
Jupiter Neurosciences has 15 employees as of Feb 5, 2024.
How much has Jupiter Neurosciences raised to-date?
As of July 05, 2023, Jupiter Neurosciences has raised a total of $2.8M (USD) since Jan 1, 2021.
Add Comparison
Total Raised to Date
$2.8M
USD
Last Update Jan 1, 2021
Current Employees
15
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts